View Resource
The aim is to present a document, which is based on current evidence and serves as a guideline for use in clinical practice. The following questions are addressed:
-
Is the use of antenatal corticosteroids (ACS) an effective therapy?
-
Who are the candidates for antenatal corticosteroid therapy?
-
Is there benefit after 34 weeks’ gestation?
-
When is the optimal time to treat?
-
Which are the optimal steroids; what is the ideal dose and route of administration?
-
Are there any contraindications to the administration of ACS?
-
Are antenatal corticosteroids indicated in women with premature rupture of membranes (PROM)?
-
Is the use of ACS recommended in pregnancies complicated by maternal diabetes mellitus?
-
Should the treatment with corticosteroids be repeated?